Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients (original) (raw)
PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS: Occurrence of Precipitating Antibodies against Pseudomonas Aeruginosa in Relation to the Concentration of Sixteen Serum Proteins and the Clinical and Radiographical Status of thi Lungs
Claudia Mugnaioli
Acta Paediatrica, 1974
View PDFchevron_right
Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients
Martin Imboden
Vaccine, 2004
View PDFchevron_right
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis
James Littlewood
Archives of Disease in Childhood, 1986
View PDFchevron_right
Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis
Henryk Mazurek
Pneumonologia i Alergologia Polska, 2014
View PDFchevron_right
INHIBITORY EFFECT OF CYSTIC FIBROSIS SERUM ON PSEUDOMONAS PHAGOCYTOSIS BY RABBIT AND HUMAN ALVEOLAR MACROPHAGES
Dorr Dearborn
Pediatric Research, 1979
View PDFchevron_right
Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
A. Turnbull, Odel Soren
View PDFchevron_right
Phagocytosis of Pseudomonas aeruginosa by polymorphonuclear leukocytes and monocytes: effect of cystic fibrosis serum
Catherine Demko
Infection and Immunity, 1982
View PDFchevron_right
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
U. Schaad
The Journal of Pediatrics, 1995
View PDFchevron_right
Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection: Epithelial cellular responses to P. aeruginosa
sarah khan
Fems Immunology and Medical Microbiology, 2010
View PDFchevron_right
Study of biological characteristics of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis and from patients with extra-pulmonary infections
Wanderley Dias da Silveira
Brazilian Journal of Infectious Diseases, 2008
View PDFchevron_right
Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection
Oana Ciofu
FEMS Immunology & Medical Microbiology, 2010
View PDFchevron_right
PrecipitatingPseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients
Maria Trancassini
European Journal of Clinical Microbiology & Infectious Diseases, 1996
View PDFchevron_right
Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by ELISA for anti-pseudomonas LPS IgG antibodies
George R Barclay
Serodiagnosis and Immunotherapy in Infectious Disease, 1990
View PDFchevron_right
Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
E. Eber
Thorax, 2010
View PDFchevron_right
Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)
Carlos Levy
Diagnostic Pathology, 2014
View PDFchevron_right
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
Alain Filloux
FEMS microbiology letters, 2017
View PDFchevron_right
The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis
Uğur Özçelik
The Turkish journal of pediatrics
View PDFchevron_right
Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs
Pearay Ogra
Infection and Immunity, 1989
View PDFchevron_right
Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis
Christopher Dowson
JAMA, 2010
View PDFchevron_right
Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis
Fotini Paliogianni
Clinical Microbiology and Infection, 2000
View PDFchevron_right
Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis
Louise Roddam
Journal of Cystic Fibrosis, 2013
View PDFchevron_right
Pseudomonas aeruginosaInfection of Respiratory Epithelium in a Cystic Fibrosis Xenograft Model
Leah Cohn
The Journal of Infectious Diseases, 2001
View PDFchevron_right
A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials
Pavel Drevinek
Journal of Cystic Fibrosis, 2019
View PDFchevron_right
Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis
James Littlewood
Archives of Disease in Childhood, 1990
View PDFchevron_right
Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients
Hannah Trøstrup Pedersen
View PDFchevron_right
Some characteristics of 452 Pseudomonas aeruginosa strains isolated from Spanish Cystic Fibrosis patients
Fernando Baquero
Médecine et Maladies Infectieuses, 1995
View PDFchevron_right
The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis
James Littlewood
Archives of Disease in Childhood, 1992
View PDFchevron_right
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa
T. Bonfield, Anna Van Heeckeren
Journal of Clinical Investigation, 1997
View PDFchevron_right
Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects
Dieter Gruenert
Infection and immunity, 1992
View PDFchevron_right
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes
UMER MUJTABA KHAN
American journal of respiratory and critical care medicine, 2014
View PDFchevron_right